The Hepatitis Diagnostic Test Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Kits and reagents, Point of care tests), By Test (Blood tests, Imaging tests, Liver biopsy), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Others).
The hepatitis diagnostic test market in 2024 addresses the demand for laboratory tests, assays, and diagnostic technologies used in the detection, screening, and monitoring of hepatitis viral infections, including hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis A virus (HAV), which pose significant public health challenges worldwide, contributing to liver cirrhosis, liver failure, and hepatocellular carcinoma (HCC) if left untreated or undiagnosed. Hepatitis diagnostic tests include serological assays (ELISA, chemiluminescent immunoassays), nucleic acid amplification tests (PCR, RNA testing), and point-of-care tests (rapid diagnostic tests, lateral flow assays), which provide essential information for disease diagnosis, staging, and treatment monitoring in clinical and public health settings. Market dynamics are driven by factors such as the increasing prevalence of viral hepatitis, the implementation of screening and vaccination programs, and advancements in diagnostic technologies that improve test sensitivity, specificity, and turnaround times. Collaboration between diagnostic manufacturers, healthcare providers, and regulatory agencies drives innovation and market growth in hepatitis diagnostic testing, enabling early detection, linkage to care, and disease management strategies to reduce the burden of viral hepatitis and improve patient outcomes.
A significant trend in the Hepatitis Diagnostic Test market is the increasing adoption of point-of-care testing (POCT) for hepatitis diagnosis. POCT enables rapid and decentralized testing, allowing healthcare providers to diagnose hepatitis infections quickly and efficiently at the point of care, such as clinics, community health centers, and remote locations. This trend is driven by the need for timely diagnosis and treatment initiation, especially in resource-limited settings and regions with high hepatitis prevalence. Furthermore, technological advancements have led to the development of portable and user-friendly POCT devices, further facilitating their integration into routine clinical practice for hepatitis screening and monitoring.
A key driver in the Hepatitis Diagnostic Test market is the rising global burden of hepatitis infections, particularly hepatitis B virus (HBV) and hepatitis C virus (HCV). Hepatitis infections pose a significant public health challenge worldwide, leading to chronic liver disease, liver cirrhosis, and hepatocellular carcinoma. The increasing incidence of hepatitis infections, fueled by factors such as unsafe injection practices, blood transfusions, and intravenous drug use, drives the demand for accurate and reliable diagnostic tests for early detection, disease monitoring, and treatment decision-making. As governments and healthcare organizations intensify efforts to combat hepatitis infections through screening, vaccination, and treatment programs, the demand for hepatitis diagnostic tests is expected to escalate.
An opportunity for market growth in the Hepatitis Diagnostic Test market lies in the expansion of screening programs for hepatitis infections. Many countries are implementing or enhancing hepatitis screening initiatives aimed at identifying undiagnosed cases, preventing disease transmission, and reducing the burden of hepatitis-related morbidity and mortality. By partnering with governments, non-governmental organizations (NGOs), and public health agencies, diagnostic test manufacturers can support the expansion of hepatitis screening programs through the provision of affordable, accurate, and accessible diagnostic tests. Additionally, educating healthcare providers and communities about the importance of hepatitis screening and early detection can further enhance the uptake of diagnostic tests and improve patient outcomes.
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Bio-Rad Laboratories Inc
Danaher
Danaher Corp
DiaSorin S.p.A.
F. Hoffmann La-Roche Ltd
Grifols, S.A.
Hologic Inc
MedMira Inc
QIAGEN
Siemens AG
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Hepatitis Diagnostic Test Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Hepatitis Diagnostic Test Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Hepatitis Diagnostic Test Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Hepatitis Diagnostic Test Market Size Outlook, $ Million, 2021 to 2030
3.2 Hepatitis Diagnostic Test Market Outlook by Type, $ Million, 2021 to 2030
3.3 Hepatitis Diagnostic Test Market Outlook by Product, $ Million, 2021 to 2030
3.4 Hepatitis Diagnostic Test Market Outlook by Application, $ Million, 2021 to 2030
3.5 Hepatitis Diagnostic Test Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Hepatitis Diagnostic Test Market Industry
4.2 Key Market Trends in Hepatitis Diagnostic Test Market Industry
4.3 Potential Opportunities in Hepatitis Diagnostic Test Market Industry
4.4 Key Challenges in Hepatitis Diagnostic Test Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Hepatitis Diagnostic Test Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Hepatitis Diagnostic Test Market Outlook By Segments
7.1 Hepatitis Diagnostic Test Market Outlook by Segments
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
8 North America Hepatitis Diagnostic Test Market Analysis And Outlook To 2030
8.1 Introduction to North America Hepatitis Diagnostic Test Markets in 2024
8.2 North America Hepatitis Diagnostic Test Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Hepatitis Diagnostic Test Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
9 Europe Hepatitis Diagnostic Test Market Analysis And Outlook To 2030
9.1 Introduction to Europe Hepatitis Diagnostic Test Markets in 2024
9.2 Europe Hepatitis Diagnostic Test Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Hepatitis Diagnostic Test Market Size Outlook By Segments, 2021-2030
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
10 Asia Pacific Hepatitis Diagnostic Test Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Hepatitis Diagnostic Test Markets in 2024
10.2 Asia Pacific Hepatitis Diagnostic Test Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Hepatitis Diagnostic Test Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
11 South America Hepatitis Diagnostic Test Market Analysis And Outlook To 2030
11.1 Introduction to South America Hepatitis Diagnostic Test Markets in 2024
11.2 South America Hepatitis Diagnostic Test Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Hepatitis Diagnostic Test Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
12 Middle East And Africa Hepatitis Diagnostic Test Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Hepatitis Diagnostic Test Markets in 2024
12.2 Middle East and Africa Hepatitis Diagnostic Test Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Hepatitis Diagnostic Test Market size Outlook by Segments, 2021-2030
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Bio-Rad Laboratories Inc
Danaher
Danaher Corp
DiaSorin S.p.A.
F. Hoffmann La-Roche Ltd
Grifols, S.A.
Hologic Inc
MedMira Inc
QIAGEN
Siemens AG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Instruments
Kits and reagents
Point of care tests
By Test
Blood tests
Imaging tests
Liver biopsy
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Hepatitis Diagnostic Test Market is one of the lucrative growth markets, poised to register a 5.4% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Bio-Rad Laboratories Inc, Danaher, Danaher Corp, DiaSorin S.p.A., F. Hoffmann La-Roche Ltd, Grifols, S.A., Hologic Inc, MedMira Inc, QIAGEN, Siemens AG
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume